Transdermal fentanyl and respiratory depression.
McLoughlin
R
R
McQuillan
R
R
D000279:Administration, Cutaneous; D000701:Analgesics, Opioid / Q000009:adverse effects*; D005283:Fentanyl / Q000009:adverse effects*; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000139:chemically induced*
D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009270:Naloxone; D005283:Fentanyl